Clover Health Investments, Corp - stock earnings
CLOV Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 AfterMarket | - / -0.0738000000 | - | - / 327.7 million | - |
CLOV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -70.5 million USD | 505.4 million USD |
| 2023Q3 | -41.5 million USD | 482.1 million USD |
| 2023Q2 | -28.8 million USD | 513.6 million USD |
| 2023Q1 | -72.6 million USD | 527.8 million USD |
| 2022Q4 | -61.6 million USD | 898.8 million USD |
| 2022Q3 | -76.3 million USD | 856.8 million USD |
| 2022Q2 | -105.4 million USD | 846.7 million USD |
| 2022Q1 | -62.9 million USD | 874.4 million USD |
| 2021Q4 | -187.2 million USD | 432.0 million USD |
| 2021Q3 | -34.5 million USD | 427.2 million USD |
| 2021Q2 | -317.6 million USD | 412.5 million USD |
| 2021Q1 | -48.4 million USD | 200.3 million USD |
| 2020Q4 | -81.6 million USD | 166.2 million USD |
| 2020Q3 | 12.8 million USD | 169.1 million USD |
| 2020Q2 | 5.4 million USD | 172.1 million USD |
| 2020Q1 | -28.2 million USD | 165.5 million USD |
| 2019Q4 | -17631 USD | ? USD |
CLOV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -213.4 million USD | 2.0 billion USD |
| 2022 | -305.4 million USD | 3.5 billion USD |
| 2021 | -604.7 million USD | 1.5 billion USD |
| 2020 | -148.7 million USD | 672.9 million USD |
| 2019 | -402.8 million USD | 462.3 million USD |
| 2018 | -201.9 million USD | 281.0 million USD |
CLOV
Price: $0.70
52 week price:
Earnings Per Share: -0.44 USD
P/E Ratio: -2.06
Exchange: NMS
Sector: Healthcare
Industry: Healthcare Plans
Volume: 6.1 million
Market Capitalization: 374.8 million